ArticleAnnals of hematology2025

Multi-courses of blinatumomab combined with reduced dose chemotherapy has been successfully used in chemo-intolerant middle to high-risk pediatric B-ALL patients with invasive fungal disease.

En-Min Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.